Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
04-07 March, 2025
Not Confirmed
Not Confirmed
05-07 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
04-07 March, 2025
Industry Trade Show
Not Confirmed
05-07 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
26 Feb 2025
// ENDPTS
https://endpts.com/boehringer-ingelheim-wins-jury-verdict-in-zantac-retrial-in-illinois/
25 Feb 2025
// BUSINESSWIRE
24 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/24/3030917/0/en/Boehringer-Ingelheim-launches-new-trivalent-poultry-vaccine-includes-protection-against-H5-avian-influenza.html
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/20/3029669/0/en/OXB-s-lentiviral-vector-manufacturing-technology-to-support-Boehringer-Ingelheim-s-newly-initiated-Phase-I-II-trial-of-first-in-class-gene-therapy-for-cystic-fibrosis.html
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/20/3029558/0/en/Boehringer-Ingelheim-and-partners-start-clinical-development-of-a-first-in-class-inhaled-gene-therapy-for-people-with-cystic-fibrosis.html
20 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/boehringer-ingelheim-pharmaceuticals-inc-welcomes-brian-hilberdink-as-president-us-human-pharma-302380906.html
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15003
Submission : 2000-09-11
Status : Active
Type : II
Certificate Number : R1-CEP 2011-311 - Rev 01
Issue Date : 2021-03-17
Type : Chemical
Substance Number : 2411
Status : Valid
Registration Number : 224MF10100
Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein
Initial Date of Registration : 2012-05-23
Latest Date of Registration :
Registrant Name : Boehringer Ingelheim Korea Ltd.
Registration Date : 2013-01-09
Registration Number : 20130109-194-I-63-01
Manufacturer Name : Boehringer Ingelheim GmbH & Co.KG
Manufacturer Address : Binger Strasse 173 55216 Ingelheim am Rhein, Germany
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14259
Submission : 1999-06-25
Status : Active
Type : II
Certificate Number : R1-CEP 1996-005 - Rev 05
Issue Date : 2015-10-08
Type : Chemical
Substance Number : 919
Status : Valid
Registration Number : 220MF10081
Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein
Initial Date of Registration : 2008-03-14
Latest Date of Registration :
NDC Package Code : 12714-049
Start Marketing Date : 2011-05-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Boehringer Ingelheim Korea Ltd.
Registration Date : 2012-09-19
Registration Number : 20120919-188-I-64-01
Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co. K.G.
Manufacturer Address : Binger Strasse 173, 55216 Ingelheim am Rhein
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19620
Submission : 2006-07-24
Status : Active
Type : II
Certificate Number : R1-CEP 2006-123 - Rev 00
Issue Date : 2012-09-25
Type : Chemical
Substance Number : 2135
Status : Valid
Registration Number : 221MF10144
Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein
Initial Date of Registration : 2009-07-09
Latest Date of Registration :
Registrant Name : Novo Nordisk Pharmaceuticals Co., Ltd.
Registration Date : 2021-10-28
Registration Number : 20211028-209-J-1132
Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co KG
Manufacturer Address : Binger Strasse 173, D-55216 Ingelheim am Rhein, Germany
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Certificate Number : R1-CEP 2002-142 - Rev 03
Issue Date : 2011-02-10
Type : Chemical
Substance Number : 1489
Status : Valid
Registration Number : 220MF10085
Registrant's Address : S. S. 11 Padana Superiore,N. 8 24040 Fornovo San Giovanni
Initial Date of Registration : 2008-03-18
Latest Date of Registration :
Registrant Name : Opella Healthcare Korea Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-45-B-117-04
Manufacturer Name : Bidachem SpA
Manufacturer Address : SS 11(Padana Superiore), 8 24040 Fornovo San Giovanni
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6926
Submission : 1987-04-06
Status : Inactive
Type : II
Certificate Number : R1-CEP 2000-147 - Rev 04
Issue Date : 2015-09-25
Type : Chemical
Substance Number : 79
Status : Withdrawn by Holder
Registration Number : 218MF10484
Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein Germany
Initial Date of Registration : 2006-05-15
Latest Date of Registration :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5822
Submission : 1985-05-29
Status : Inactive
Type : II
Certificate Number : R1-CEP 2009-274 - Rev 00
Issue Date : 2016-03-17
Type : Chemical
Substance Number : 2303
Status : Withdrawn by Holder
Registration Number : 218MF10483
Registrant's Address : Binger Strasse 173, 55216 Ingelheim am Rhein Germany
Initial Date of Registration : 2006-05-15
Latest Date of Registration :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18148
Submission : 2005-02-21
Status : Inactive
Type : II
Certificate Number : R1-CEP 2002-010 - Rev 02
Issue Date : 2010-07-08
Type : Chemical
Substance Number : 922
Status : Withdrawn by Holder
Registration Number : 218MF10395
Registrant's Address : S. S. 11 Padana Superior N. 8 24040 Fornovo S. Giovanni BG Italy
Initial Date of Registration : 2006-03-20
Latest Date of Registration :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21413
Submission : 2008-03-12
Status : Active
Type : II
Certificate Number : R0-CEP 2019-186 - Rev 00
Issue Date : 2020-04-02
Type : Chemical
Substance Number : 2416
Status : Valid
Registrant Name : Boehringer Ingelheim Korea Ltd.
Registration Date : 2022-05-17
Registration Number : 20220517-209-J-1298
Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co. K.G.
Manufacturer Address : Binger Strasse 173, 55216 Ingelheim am Rhien, Germany
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14258
Submission : 1999-06-25
Status : Active
Type : II
Certificate Number : CEP 1997-004 - Rev 05
Issue Date : 2024-05-30
Type : Chemical
Substance Number : 687
Status : Valid
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3622
Submission : 1979-08-23
Status : Inactive
Type : II
Certificate Number : R1-CEP 2000-064 - Rev 01
Issue Date : 2008-09-09
Type : Chemical
Substance Number : 106
Status : Withdrawn by Holder
Registration Number : 221MF10105
Registrant's Address : Binger Strasse 173, 55216 Ingelheim am Rhein
Initial Date of Registration : 2009-05-27
Latest Date of Registration :
Details:
BI 3720931 is a first-in-class, inhaled lentiviral vector-based gene therapy designed to insert a functional copy of the CFTR gene in the DNA of airway epithelial cells for treating cystic fibrosis.
Lead Product(s): BI 3720931
Therapeutic Area: Genetic Disease Brand Name: BI 3720931
Study Phase: Phase I/ Phase IIProduct Type: Cell and Gene therapy
Sponsor: OXB
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 20, 2025
Lead Product(s) : BI 3720931
Therapeutic Area : Genetic Disease
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : OXB
Deal Size : Inapplicable
Deal Type : Inapplicable
OXB’s Technology to Support Boehringer’s Gene Therapy for Cystic Fibrosis
Details : BI 3720931 is a first-in-class, inhaled lentiviral vector-based gene therapy designed to insert a functional copy of the CFTR gene in the DNA of airway epithelial cells for treating cystic fibrosis.
Product Name : BI 3720931
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
February 20, 2025
Details:
BI 1810631 (zongertinib) is an investigational oral HER2 tyrosine kinase inhibitor (TKI) in development being investigated in patients with advanced NSCLC with activating HER2 mutations.
Lead Product(s): Zongertinib
Therapeutic Area: Oncology Brand Name: BI 1810631
Study Phase: Phase IProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 19, 2025
Lead Product(s) : Zongertinib
Therapeutic Area : Oncology
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Zongertinib Receives Priority Review for HER2 (ERBB2)-mutant Advanced NSCLC
Details : BI 1810631 (zongertinib) is an investigational oral HER2 tyrosine kinase inhibitor (TKI) in development being investigated in patients with advanced NSCLC with activating HER2 mutations.
Product Name : BI 1810631
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 19, 2025
Details:
BI 1015550 (nerandomilast) is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B) that is being studied as a potential treatment for IPF.
Lead Product(s): Nerandomilast
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: BI 1015550
Study Phase: Phase IIIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 10, 2025
Lead Product(s) : Nerandomilast
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Boehringer’s Nerandomilast Hits Primary Endpoint in Phase III FIBRONEER-ILD
Details : BI 1015550 (nerandomilast) is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B) that is being studied as a potential treatment for IPF.
Product Name : BI 1015550
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 10, 2025
Details:
BI 1015550 (nerandomilast) is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B) that is being studied as a potential treatment for progressive pulmonary fibrosis.
Lead Product(s): Nerandomilast
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: BI 1015550
Study Phase: Phase IIIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 10, 2025
Lead Product(s) : Nerandomilast
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Boehringer Widens Fibrosis Drug's Potential After 2nd Ph. 3 Win
Details : BI 1015550 (nerandomilast) is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B) that is being studied as a potential treatment for progressive pulmonary fibrosis.
Product Name : BI 1015550
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 10, 2025
Details:
BI 425809(iclepertin), an investigational oral inhibitor of glycine transporter 1 (GlyT1), studied as a potential treatment for cognitive impairment in adults with schizophrenia.
Lead Product(s): Iclepertin
Therapeutic Area: Neurology Brand Name: BI 425809
Study Phase: Phase IIIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 16, 2025
Lead Product(s) : Iclepertin
Therapeutic Area : Neurology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia
Details : BI 425809(iclepertin), an investigational oral inhibitor of glycine transporter 1 (GlyT1), studied as a potential treatment for cognitive impairment in adults with schizophrenia.
Product Name : BI 425809
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 16, 2025
Details:
BI 425809 (iclepertin) is a glycine transporter 1 (GlyT1) inhibitor, small molecule drug candidate, which is being evaluated for the treatment of patients with schizophrenia.
Lead Product(s): Iclepertin
Therapeutic Area: Psychiatry/Psychology Brand Name: BI 425809
Study Phase: Phase IIIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 16, 2025
Lead Product(s) : Iclepertin
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Boehringer's Schizophrenia Drug Fails Trio of Phase 3 Trials
Details : BI 425809 (iclepertin) is a glycine transporter 1 (GlyT1) inhibitor, small molecule drug candidate, which is being evaluated for the treatment of patients with schizophrenia.
Product Name : BI 425809
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 16, 2025
Details:
Under the expanded collaboration agreement, Boehringer Ingelheim will be responsible for the future development and commercialization of antibody products for the Cancer.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: DiscoveryProduct Type: Antibody-drug Conjugate
Recipient: Oxford Biotherapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Expanded Collaboration January 09, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Recipient : Oxford Biotherapeutics
Deal Size : Undisclosed
Deal Type : Expanded Collaboration
Boehringer Ingelheim Acquires License for Novel Antibody Cancer Treatments
Details : Under the expanded collaboration agreement, Boehringer Ingelheim will be responsible for the future development and commercialization of antibody products for the Cancer.
Product Name : Undisclosed
Product Type : Antibody-drug Conjugate
Upfront Cash : Undisclosed
January 09, 2025
Details:
The collaboration aims to commercial scale to manufacture Luvelta (luveltamab tazevibulin), Sutro’s Tubulin FRα-targeting ADC designed to treat a broad range of patients with ovarian cancer.
Lead Product(s): Luveltamab Tazevibulin,Pegfilgrastim
Therapeutic Area: Oncology Brand Name: Luvelta
Study Phase: Phase II/ Phase IIIProduct Type: Antibody-drug Conjugate
Recipient: Sutro Biopharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration January 07, 2025
Lead Product(s) : Luveltamab Tazevibulin,Pegfilgrastim
Therapeutic Area : Oncology
Highest Development Status : Phase II/ Phase III
Recipient : Sutro Biopharma
Deal Size : Undisclosed
Deal Type : Collaboration
Sutro, Boehringer Partner on Cell-Free Biopharma Manufacturing Scale-Up
Details : The collaboration aims to commercial scale to manufacture Luvelta (luveltamab tazevibulin), Sutro’s Tubulin FRα-targeting ADC designed to treat a broad range of patients with ovarian cancer.
Product Name : Luvelta
Product Type : Antibody-drug Conjugate
Upfront Cash : Undisclosed
January 07, 2025
Details:
Spevigo (spesolimab) is an IL-36 blocker, given by IV infusion, has been approved by CDSCO as the first treatment option for generalized pustular psoriasis flares in adults.
Lead Product(s): Spesolimab
Therapeutic Area: Dermatology Brand Name: Undisclosed
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 13, 2024
Lead Product(s) : Spesolimab
Therapeutic Area : Dermatology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Malaysia Approves Spesolimab for Generalised Pustular Psoriasis Flares in Adults
Details : Spevigo (spesolimab) is an IL-36 blocker, given by IV infusion, has been approved by CDSCO as the first treatment option for generalized pustular psoriasis flares in adults.
Product Name : Undisclosed
Product Type : Large molecule
Upfront Cash : Not Applicable
December 13, 2024
Details:
The acquisition strengthens Torrent’s existing diabetes portfolio by adding Cospiaq (empagliflozin), Cospiaq Met (empagliflozin & metformin) and Xilingio (empagliflozin & linagliptin) from Boehringer.
Lead Product(s): Empagliflozin
Therapeutic Area: Endocrinology Brand Name: Undisclosed
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Torrent Pharmaceuticals Limited
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition December 04, 2024
Lead Product(s) : Empagliflozin
Therapeutic Area : Endocrinology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Torrent Pharmaceuticals Limited
Deal Size : Undisclosed
Deal Type : Acquisition
Torrent Pharma Inks Agreement with Boehringer Ingelheim to Acquire 3 Anti-Diabetes Brands
Details : The acquisition strengthens Torrent’s existing diabetes portfolio by adding Cospiaq (empagliflozin), Cospiaq Met (empagliflozin & metformin) and Xilingio (empagliflozin & linagliptin) from Boehringer.
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Undisclosed
December 04, 2024
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : ATRAVET 10 MG INJECTABLE
Dosage Strength : 10MG/ML
Packaging : 50 ML
Approval Date :
Application Number : 53023
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Italy
Acetaminophen/Paracetamol; Chlorpheniramine
Dosage Form :
Brand Name : Zerinetta C.M.
Dosage Strength : 10 Supp 150 Mg + 1 Mg ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN AND CODEINE...
Dosage Strength : 300MG;30MG
Packaging :
Approval Date : 1982-01-01
Application Number : 84656
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN AND CODEINE...
Dosage Strength : 300MG;60MG
Packaging :
Approval Date : 1982-01-01
Application Number : 84667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN AND CODEINE...
Dosage Strength : 500MG;30MG
Packaging :
Approval Date : 1989-04-25
Application Number : 89512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN AND CODEINE...
Dosage Strength : 300MG;15MG
Packaging :
Approval Date : 1982-01-01
Application Number : 84659
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN AND CODEINE...
Dosage Strength : 500MG;15MG
Packaging :
Approval Date : 1989-04-25
Application Number : 89511
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN AND CODEINE...
Dosage Strength : 500MG;60MG
Packaging :
Approval Date : 1989-04-25
Application Number : 89513
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Brand Name : ROXICET 5/500
Dosage Strength : 500MG;5MG
Packaging :
Approval Date : 1989-01-12
Application Number : 89775
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Brand Name : ROXILOX
Dosage Strength : 500MG;5MG
Packaging :
Approval Date : 1995-07-03
Application Number : 40061
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Acetaminophen/Paracetamol; Chlorpheniramine
Dosage Form :
Dosage Strength : 10 Supp 150 Mg + 1 Mg ...
Packaging :
Brand Name : Zerinetta C.M.
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Afatinib 20Mg 28 Combined Oral...
Dosage Strength : 28 cpr riv 20 mg
Packaging :
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Afatinib 30Mg 28 Combined Oral...
Dosage Strength : 28 cpr riv 30 mg
Packaging :
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Afatinib 40Mg 28 Combined Oral...
Dosage Strength : 28 cpr riv 40 mg
Packaging :
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Afatinib 50Mg 28 Combined Oral...
Dosage Strength : 28 cpr riv 50 mg
Packaging :
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 20 mg
Packaging : Blister, endose
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 30 mg
Packaging : Blister, endose
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 40 mg
Packaging : Blister, endose
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 50 mg
Packaging : Blister, endose
Brand Name : Giotrif
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Sweden
Dosage Form : FILM COATED PILL
Dosage Strength : 20 MG
Packaging :
Brand Name : GIOTRIF
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Inspections and registrations
District Decision : No Action Indicated
Inspection End Date : 2017-05-26
City : Malgrat de Mar
State :
Country/Area : ES
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2017-05-26
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-03-17
City : Vienna
State :
Country/Area : AT
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-03-17
District Decision : No Action Indicated
Inspection End Date : 2015-09-25
City : Malgrat de Mar
State :
Country/Area : ES
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2015-09-25
District Decision : No Action Indicated
Inspection End Date : 2015-08-14
City : Saint Joseph
State : MO
Country/Area : US
Zip : 64506-2002
District : KAN
Center : CVM
Project Area : Monitoring of Marketed Animal Dr...
District Decision : No Action Indicated
Inspection End Date : 2015-08-14
District Decision : No Action Indicated
Inspection End Date : 2015-08-14
City : Columbus
State : OH
Country/Area : US
Zip : 43228-9579
District : CIN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2015-08-14
District Decision : No Action Indicated
Inspection End Date : 2015-06-26
City : Columbus
State : OH
Country/Area : US
Zip : 43228-9579
District : CIN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2015-06-26
District Decision : No Action Indicated
Inspection End Date : 2015-01-23
City : Ingelheim Am Rhein
State :
Country/Area : DE
Zip :
District : ORA
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2015-01-23
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-11-11
City : Vienna
State :
Country/Area : AT
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-11-11
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-06-26
City : Columbus
State : OH
Country/Area : US
Zip : 43228-9579
District : CIN
Center : CDER
Project Area : Postmarket Surv. and Epidemiolog...
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-06-26
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-06-12
City : Saint Joseph
State : MO
Country/Area : US
Zip : 64506-2002
District : KAN
Center : CVM
Project Area : Monitoring of Marketed Animal Dr...
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-06-12
ABOUT THIS PAGE
Boehringer Ingelheim GmbH is a supplier offers 86 products (APIs, Excipients or Intermediates).
Find a price of Epinastine Hydrochloride bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim GmbH
Find a price of Ipratropium Bromide bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim GmbH
Find a price of Repaglinide bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim GmbH
Find a price of Digoxin bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Epinephrine bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP offered by Boehringer Ingelheim GmbH
Find a price of Salbutamol Sulphate bulk with DMF, CEP offered by Boehringer Ingelheim GmbH
Find a price of Scopolamine Hydrobromide bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Dipyridamole bulk with DMF offered by Boehringer Ingelheim GmbH
Find a price of Hyoscine Butyl Bromide bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Tiotropium Bromide bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Atropine bulk offered by Boehringer Ingelheim GmbH
Find a price of Atropine Sulfate bulk offered by Boehringer Ingelheim GmbH
Find a price of Brotizolam bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Clenbuterol Hydrochloride bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Clonidine bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Dihydroergotamine Mesylate bulk offered by Boehringer Ingelheim GmbH
Find a price of Epinephrine Bitartrate bulk offered by Boehringer Ingelheim GmbH
Find a price of Ergotamine Tartrate bulk offered by Boehringer Ingelheim GmbH
Find a price of Etilefrine bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Fenoterol Hydrobromide bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Homatropine Hydrobromide bulk offered by Boehringer Ingelheim GmbH
Find a price of Homatropine Methylbromide bulk offered by Boehringer Ingelheim GmbH
Find a price of Hyoscyamine Sulfate bulk offered by Boehringer Ingelheim GmbH
Find a price of Methocarbamol bulk with DMF offered by Boehringer Ingelheim GmbH
Find a price of Methylphenidate Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Moxonidine bulk offered by Boehringer Ingelheim GmbH
Find a price of Phenylephrine Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Pramipexole Dihydrochloride bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Scopolamine bulk offered by Boehringer Ingelheim GmbH
Find a price of Tramazoline Hydrochloride Monohydrate bulk with CEP offered by Boehringer Ingelheim GmbH
Find a price of Trospium Chloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Zolpidem Tartrate bulk offered by Boehringer Ingelheim GmbH
Find a price of Medium / Medium Additives-P-Media bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Beperuminogen per plasmid bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Medium / Medium Additives / G-Medium bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Medium / Medium Additives-I-Medium bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Medium / Medium Additives ・ F-Media bulk with JDMF offered by Boehringer Ingelheim GmbH
Find a price of Amphetamine bulk offered by Boehringer Ingelheim GmbH
Find a price of Beta-2 bulk offered by Boehringer Ingelheim GmbH
Find a price of Brompheniramine Maleate bulk offered by Boehringer Ingelheim GmbH
Find a price of Caffeine bulk offered by Boehringer Ingelheim GmbH
Find a price of Calcium Polycarbophil bulk offered by Boehringer Ingelheim GmbH
Find a price of Camptothecine bulk offered by Boehringer Ingelheim GmbH
Find a price of Crotamiton bulk offered by Boehringer Ingelheim GmbH
Find a price of Dexrazoxane bulk offered by Boehringer Ingelheim GmbH
Find a price of Digoxin bulk offered by Boehringer Ingelheim GmbH
Find a price of Dihydroergotoxine Mesylate bulk offered by Boehringer Ingelheim GmbH
Find a price of Doxapram Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Esmolol Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Fentanyl bulk offered by Boehringer Ingelheim GmbH
Find a price of Fentanyl Citrate bulk offered by Boehringer Ingelheim GmbH
Find a price of Glycopyrronium Bromide bulk offered by Boehringer Ingelheim GmbH
Find a price of Guaifenesin bulk offered by Boehringer Ingelheim GmbH
Find a price of Isoproterenol Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of L-Lactide bulk offered by Boehringer Ingelheim GmbH
Find a price of Lanthanum Carbonate bulk offered by Boehringer Ingelheim GmbH
Find a price of Lobeline Sulfate bulk offered by Boehringer Ingelheim GmbH
Find a price of Meloxicam bulk offered by Boehringer Ingelheim GmbH
Find a price of Metaproterenol Hemisulfate bulk offered by Boehringer Ingelheim GmbH
Find a price of Metaxalone bulk offered by Boehringer Ingelheim GmbH
Find a price of Methadol Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Methadone Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Methscopolamine Bromide bulk offered by Boehringer Ingelheim GmbH
Find a price of Methscopolamine Nitrate bulk offered by Boehringer Ingelheim GmbH
Find a price of Metoclopramide bulk offered by Boehringer Ingelheim GmbH
Find a price of Milrinone bulk offered by Boehringer Ingelheim GmbH
Find a price of Physostigmine Salicylate bulk offered by Boehringer Ingelheim GmbH
Find a price of Pilocarpine Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Ranitidine Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Scopolamine Hydrobromide bulk offered by Boehringer Ingelheim GmbH
Find a price of Theophylline bulk offered by Boehringer Ingelheim GmbH
Find a price of Tiotropium Bromide bulk offered by Boehringer Ingelheim GmbH
Find a price of Yohimbine Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of PRODUCTION AND DISTRIBUTION FACILITY IN DANBURY, CONNECTICUT bulk offered by Boehringer Ingelheim GmbH
Find a price of NR-LU-10 MURINE MONOCLONAL ANTIBODY FAB FRAGMENT (NOFETUMOMAB) AND PHENTHIOATE LIGAND BULK MATERIAL FOR ONCOTRAC KIT (NEORX) bulk offered by Boehringer Ingelheim GmbH
Find a price of COPOLYMERS OF TRIMETHYLENE CARBONATE WITHL- OR D,L-LACTIDE bulk offered by Boehringer Ingelheim GmbH
Find a price of rTNF-alpha Drug Substance bulk offered by Boehringer Ingelheim GmbH
Find a price of IFN-OMEGA bulk offered by Boehringer Ingelheim GmbH
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN RIDGEFIELD, CONNECTICUT. bulk offered by Boehringer Ingelheim GmbH
Find a price of PHYSOSTIGMINE SALICYLATE (SYNTHETIC bulk offered by Boehringer Ingelheim GmbH
Find a price of INTERLEUKIN-12 BULK SUBSTANCE bulk offered by Boehringer Ingelheim GmbH
Find a price of ESERETHOL bulk offered by Boehringer Ingelheim GmbH
Find a price of POLY-(D,L-LACTIDE-CO-GLYCOLIDE) 50:50 bulk offered by Boehringer Ingelheim GmbH
Find a price of Bromhexine Hydrochloride bulk offered by Boehringer Ingelheim GmbH
Find a price of Penethamate Hydriodide bulk offered by Boehringer Ingelheim GmbH